Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Expert Opinion on Biological Therapy|April 23, 2004
Overcoming antigenic diversity and improving vaccines using DNA shuffling and screening technologiesChristopher P Locher, Volker Heinrichs, Doris Apt, et al.
DNA and Cell Biology|April 7, 2005
DNA shuffling and screening strategies for improving vaccine efficacyChristopher P Locher, Madan Paidhungat, Robert G Whalen, et al.
Current Opinion in Molecular Therapeutics|March 12, 2004
Development of novel vaccines using DNA shuffling and screening strategiesChristopher P Locher, Nay Wei Soong, Robert G Whalen, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2003
5HT1A serotonin receptor agonists inhibit Plasmodium falciparum by blocking a membrane channelChristopher P Locher, Peter C Ruben, Jiri Gut, et al.
DNA and Cell Biology|September 7, 2002
Enhancement of antibody responses to an HIV-2 DNA envelope vaccine using an expression vector containing a constitutive transport elementChristopher P Locher, Stephanie A Witt, Brittany M Ashlock, et al.
Microbiology and Molecular Biology Reviews : MMBR|May 13, 2021
The CD8<sup>+</sup> T Cell Noncytotoxic Antiviral ResponsesMaelig G Morvan, Fernando C Teque, Christopher P Locher, et al.
DNA and Cell Biology|March 6, 2004
Evaluation of genetic immunization adjuvants to improve the effectiveness of a human immunodeficiency virus type 2 (HIV-2) envelope DNA vaccineChristopher P Locher, Stephanie A Witt, Brittany M Ashlock, et al.
AIDS Research and Human Retroviruses|February 13, 2003
Expression patterns of phenotypic markers on lymphocytes from human immunodeficiency virus type 2-infected baboonsChristopher P Locher, Sue Fujimura, Krishna K Murthy, et al.
Immunology Letters|December 23, 2003
Enhancement of a human immunodeficiency virus env DNA vaccine using a novel polycationic nanoparticle formulationChristopher P Locher, David Putnam, Robert Langer, et al.
The Journal of General Virology|March 24, 2005
Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activationChristopher P Locher, Stephanie A Witt, Rachel Kassel, et al.
Pageof 2